N
TOI icon

Nuveen’s The Oncology Institute TOI Stock Holding History

Nuveen’s Portfolio TOI Stock Details TOI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$292K Buy
95,264
+18,592
+24% +$57K ﹤0.01% 3014
2025
Q4 		$273K Hold
76,672
– – ﹤0.01% 3067
2025
Q3 		$268K Hold
76,672
– – ﹤0.01% 3087
2025
Q2 		$157K Buy
+76,672
New +$192K ﹤0.01% 3201
2023
Q2 		– Sell
-52,343
Closed -$497K – 3293
2023
Q1 		$497K Hold
52,343
– – ﹤0.01% 2804
2022
Q4 		$497K Buy
52,343
+3,537
+7% +$9.93K ﹤0.01% 2885
2022
Q3 		$464K Buy
48,806
+22,337
+84% +$131K ﹤0.01% 2972
2022
Q2 		$251K Buy
+26,469
New +$193K ﹤0.01% 3126

Other funds holding TOI

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $607M AUM 57.92% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return